- Home
- DOUG vs CBUS Comparison
DOUG vs CBUS Comparison
Compare DOUG & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOUG | CBUS |
|---|---|---|
| Founded | 1911 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Agricultural Chemicals |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.5M | 116.2M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | DOUG | CBUS |
|---|---|---|
| Price | $1.46 | $1.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.33 |
| AVG Volume (30 Days) | ★ 488.6K | 100.6K |
| Earning Date | 11-02-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.68 | 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $955,578,000.00 | $3,639,000.00 |
| Revenue This Year | $0.59 | $42.75 |
| Revenue Next Year | $7.00 | $139.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.42 | $1.09 |
| 52 Week High | $3.03 | $4.19 |
Technical Indicators
Market Signals| Indicator | DOUG | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 31.55 | 33.60 |
| Support Level | N/A | $1.22 |
| Resistance Level | $1.84 | $1.62 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 9.80 |
Price Performance
Historical ComparisonAbout DOUG Douglas Elliman Inc.
Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.